WASHINGTON (AP) Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the dea… [+2628 chars]Read More
Second patient death reported with gene therapy for muscular dystrophy AP News
